Belvedere Trading LLC Aclaris Therapeutics, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
SELL
$6.56 - $10.95 $1,128 - $1,883
-172 Reduced 1.11%
15,386 $105,000
Q2 2023

Aug 08, 2023
SELL
$7.89 - $10.64 $131,155 - $176,868
-16,623 Reduced 51.65%
15,558 $161,000
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $227,519 - $577,648
32,181 New
32,181 $260,000
Q2 2021

Jul 23, 2021
SELL
$17.08 - $29.6 $281,358 - $487,600
-16,473 Closed
0 $0
Q1 2021

Apr 27, 2021
BUY
$5.86 - $27.73 $96,531 - $456,796
16,473 New
16,473 $415,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email